MRI Muscle in Neuromuscular Disorders — Generic Standard Protocol
Required Protocol at a Glance
Mandatory core sequences for this examination. Detailed rationale, conditional additions and optimisation notes are provided later in the protocol.
MRIninja Knowledge Base | Master / General Protocol Page Anatomical domain: skeletal muscle of the limbs, girdle, and trunk in the context of inherited, inflammatory, and neurogenic muscle disease Version 1.0 — July 2026
1. Executive Summary
MRI has become an established, non-invasive tool for the diagnostic work-up, differential diagnosis, and longitudinal monitoring of neuromuscular disorders, a heterogeneous group of conditions that includes inherited myopathies and muscular dystrophies, idiopathic inflammatory myopathies, denervating neuropathies and motor neuron disease, and a range of metabolic and toxic myopathies. Unlike the muscle-trauma and muscle-tumor/infection master pages on this platform, the guiding clinical question in this domain is rarely “what is this focal lesion?” but rather “what is the pattern of muscle involvement — which muscles are affected, to what degree, and with what combination of oedema-like signal and fatty replacement — and does that pattern point toward a specific diagnostic category?” a growing body of literature supports the use of magnetic resonance imaging as a potential biomarker for disease severity in the hereditary myopathies.
Compared with electromyography (EMG) and nerve conduction studies, which remain the electrophysiological reference standard for characterising denervation and for localising a nerve lesion, MRI offers a non-invasive, well-tolerated, and topographically comprehensive view of the muscle compartment itself, including muscles that are difficult or uncomfortable to sample by needle EMG MRI offers a distinct advantage over electromyography, not only in diagnosing muscle denervation, but also in determining its aetiology. Compared with muscle biopsy, MRI is non-invasive and can survey many muscles simultaneously, which is particularly valuable for identifying a patchy or asymmetric pattern of involvement and for guiding the radiologist or clinician toward the most informative biopsy site, but MRI does not replace histopathological and genetic diagnosis. Compared with CT and ultrasound, MRI provides superior soft-tissue contrast for distinguishing muscle, fat, and oedema, and — unlike CT — avoids cumulative ionising radiation, which is a material consideration given that this patient group is frequently imaged repeatedly over years for diagnosis and monitoring.
This generic master page covers the shared technical backbone across the principal neuromuscular indications for muscle MRI:
- Inherited myopathies and muscular dystrophies — where MRI characterises the pattern and degree of fatty replacement of specific muscles, which is often disease-specific enough to narrow the differential before genetic testing;
- Idiopathic inflammatory myopathies (dermatomyositis, polymyositis, immune-mediated necrotizing myopathy, inclusion body myositis, and related overlap syndromes) — where MRI characterises muscle and fascial oedema-like signal as a marker of disease activity, alongside chronic fatty change as a marker of damage;
- Denervation from neuropathies, plexopathies, radiculopathies, and motor neuron disease — where MRI depicts a topographically informative pattern of muscle oedema-like signal (subacute) and fatty atrophy (chronic) that follows a myotome, peripheral nerve, or plexus distribution;
- Muscle oedema pattern analysis and chronic fatty replacement as cross-cutting technical themes that recur across all of the above categories and are addressed once, generically, on this page rather than being repeated in every child page.
This generic protocol is designed to detect and characterise diffuse, patterned, or multi-compartmental muscle signal abnormality — oedema-like change and fatty replacement — across a comprehensive but tailored set of muscles, and to support pattern-recognition-based diagnostic reasoning. It is not designed to:
- provide a genetic or histological diagnosis on its own; MRI narrows the differential and guides further work-up but is not a substitute for genetic testing or biopsy where these are indicated;
- characterise a discrete, focal soft-tissue mass, which should follow the dedicated “MRI Muscle in Tumors and Infection” master page and pathway rather than this one;
- serve as the primary diagnostic tool for acute muscle trauma, which follows the dedicated “MRI Muscle in Trauma and Mechanical Disorders” master page;
- substitute for electrophysiological localisation and severity grading of a neuropathy, which remains a complementary rather than a replaced investigation;
- provide whole-body or multi-region coverage by default — this generic page describes a regional (single-limb or limb-girdle) protocol and explicitly routes to a dedicated whole-body/multi-segment child protocol when the clinical picture requires broader survey (see Section 2.1).
1.1 Core strengths
- High soft-tissue contrast for distinguishing normal muscle, oedema-like signal, and fatty replacement, which underpins both diagnostic pattern recognition and quantitative/semi-quantitative disease monitoring.
- Comprehensive, non-invasive, repeatable survey of multiple muscles and compartments in a single sitting, well suited to a patient population that is frequently imaged longitudinally over years.
- Ability to detect a topographically specific pattern of involvement (e.g., selective sparing or selective involvement of particular muscles) that can be highly informative for narrowing the differential diagnosis among genetically and clinically overlapping conditions MRI allows the spatially resolved detection of characteristic patterns of muscle involvement, helps to limit the range of differential diagnoses, and guides muscle biopsies as well as genetic analysis.
- Quantitative fat-fraction techniques (Dixon-based) provide an increasingly validated, reproducible outcome measure for clinical trials and longitudinal monitoring, complementing the traditional semi-quantitative visual grading scales.
1.2 Intrinsic limitations of the generic protocol
A generic protocol for this indication group is a compromise between breadth of anatomical coverage, acquisition time, and diagnostic specificity, and this trade-off is particularly acute here because many neuromuscular disorders require assessment of multiple non-contiguous muscle groups (e.g., both thighs and both calves, or the whole spine-innervated myotome) to reveal a diagnostically meaningful pattern.
- Signal changes are frequently non-specific in isolation: oedema-like signal on fluid-sensitive sequences is seen in inflammatory myopathy, subacute denervation, DOMS/overuse, early muscular dystrophy, and other processes; it must always be interpreted together with distribution pattern, chronicity, and clinical context rather than as a stand-alone diagnostic feature.
- A single-region protocol may miss the diagnostically informative pattern: many muscular dystrophies and several inflammatory myopathy subtypes are recognised specifically by which muscles are relatively spared versus selectively involved across a wider region (e.g., thigh and calf together, or bilateral comparison), so an unnecessarily restricted field of view can produce a normal-appearing study that misses the pattern entirely.
- Semi-quantitative visual grading (e.g., the widely used four-point scale for fatty infiltration) remains observer-dependent, and while quantitative fat-fraction mapping addresses this, it is not yet universally available or standardised across departments.
- MRI has limited ability to reliably distinguish acute/subacute denervation change from other causes of muscle oedema, and dedicated MR neurography of the causative nerve, where feasible, adds specificity that muscle imaging alone cannot provide.
- Contrast is not a routine requirement for the great majority of studies in this indication group, in contrast to the tumor/infection master page; its selective role is described in Section 6.
2. Main Clinical Indications
2.1 Standard Indications
The generic regional protocol is appropriate as the first dedicated muscle-imaging study for the majority of referrals in this indication group: a patient with unexplained proximal or limb-girdle weakness in whom an inherited myopathy or muscular dystrophy is suspected, where imaging aims to characterise the pattern and degree of muscle involvement and to help direct biopsy or genetic testing; a patient with suspected idiopathic inflammatory myopathy in whom imaging is requested to assess disease activity (oedema-like signal) and chronic damage (fatty replacement) and, in some centres, to help select a biopsy site; a patient with a known or suspected focal neuropathy, plexopathy, or radiculopathy in whom imaging of the corresponding muscle territory can support electrophysiological findings, particularly when EMG is equivocal, poorly tolerated, or when the causative lesion itself needs to be sought; and monitoring of a previously characterised neuromuscular disorder over time, where a comparable, reproducible protocol supports assessment of disease progression. In each of these scenarios the generic protocol — typically covering bilateral thighs, bilateral calves, or another clinically indicated paired region with a standard set of sequences — is usually sufficient to answer the immediate question of presence, distribution, and rough severity of muscle involvement. A dedicated child protocol becomes necessary once the clinical picture points toward a specific need: whole-body or extended multi-segment MRI is required for widespread or unpredictable-distribution disease (e.g., some early-onset or congenital myopathies, some inflammatory myopathy subtypes with trunk/paraspinal or bulbar involvement, and clinical trial contexts using standardised whole-body fat-referenced protocols); dedicated MR neurography is required when a specific, localisable nerve or plexus lesion is suspected as the cause of denervation and needs to be directly visualised; quantitative fat-fraction/T2-mapping protocols are required for clinical trial or research-grade longitudinal monitoring beyond routine semi-quantitative clinical grading; and a discrete focal mass or suspected infective collection identified incidentally during a neuromuscular work-up should be redirected to the dedicated tumor/infection pathway rather than pursued within this protocol.
2.2 Urgent Red Flags Requiring Expedited or Emergency Imaging
The great majority of indications in this domain are diagnostic or monitoring studies performed in a non-emergency, outpatient setting, and this generic protocol should not be artificially weighted with emergency content that does not reflect real practice. A small number of scenarios do, however, warrant expedited assessment or a change in clinical pathway rather than routine outpatient scheduling; in most of these, the emergency is clinical/laboratory rather than MRI-driven, and imaging plays a supportive rather than a primary emergency role.
| Red flag scenario | Recommended action |
|---|---|
| Rapidly progressive severe weakness with respiratory compromise or bulbar involvement (e.g., severe/fulminant inflammatory myopathy, an acute neuromuscular emergency such as Guillain-Barré–spectrum disease) | This is a clinical/neurological emergency; do not await elective MRI scheduling — prioritise clinical and respiratory assessment, with imaging arranged to support rather than delay management |
| Suspected rhabdomyolysis with markedly elevated creatine kinase and risk of acute kidney injury or compartment syndrome | Prioritise clinical/laboratory management (hydration, renal monitoring, compartment pressure assessment if indicated); MRI is not the primary emergency investigation and should not delay treatment |
| New, rapidly enlarging, painful focal muscle swelling in a patient under neuromuscular work-up | Reconsider the differential — this presentation is atypical for most inherited/inflammatory myopathies and should prompt an expedited study following the dedicated tumor/infection pathway rather than the generic neuromuscular protocol |
| Suspected acute compartment syndrome from any cause in this patient population | Clinical–pressure emergency; refer immediately for surgical assessment, do not await MRI |
3. Preparation Reference
Universal MRI safety screening (implants, devices, claustrophobia) belongs to the general MRI preparation page and is not repeated here.
3.1 Anatomy-Specific Preparation Items
- Symmetry and bilateral coverage planning: because pattern recognition in this indication group depends heavily on comparing muscle involvement between and within limbs, the request and the technologist planning should confirm in advance which regions require bilateral coverage (e.g., both thighs) rather than assuming a unilateral, symptom-side-only study, which is a common and consequential planning error carried over from trauma-style referrals.
- Mobility and positioning tolerance: many patients in this population have significant weakness, contractures, or fatigue, and may not tolerate prolonged positioning or repeated repositioning between regions; this should be anticipated at booking (e.g., allowing extra table time, or splitting a very extensive survey across more than one visit if genuinely necessary) rather than discovered mid-examination.
- Respiratory or bulbar involvement: patients with more advanced inflammatory myopathy, motor neuron disease, or certain muscular dystrophies may have reduced respiratory reserve or swallowing difficulty; positioning and any breath-hold requirements (relevant mainly for trunk/paraspinal imaging) should be adjusted accordingly, and the department should have a plan for managing a patient who cannot lie flat or still for the full protocol.
- Prior biopsy sites: biopsy-related post-procedural change (localised oedema, haematoma, scarring) should be documented, since it can be mistaken for disease-related signal change if the biopsy history is not known, and because imaging performed shortly after biopsy at the same site can be difficult to interpret.
- Metal/hardware: relevant mainly for artefact planning; less commonly a primary consideration in this indication group than in trauma or oncological imaging, but should still be documented.
- Patient history that changes the protocol: known genetic diagnosis or strong family history (helps target which muscle groups are most informative to image, since specific dystrophies and myopathies have well-described, disease-specific muscle-involvement patterns that can guide FOV selection); known inflammatory myopathy subtype or myositis-specific autoantibody status (relevant to whether trunk/paraspinal or additional regions should be added); recent significant exercise (can produce transient muscle signal change that mimics or masks pathological oedema, exactly as in the trauma protocol, and should be documented).
3.2 Patient Positioning on the MRI System
- Position: supine for the great majority of limb-girdle and limb studies; comfort and the ability to remain still for a potentially longer, multi-region examination are more consequential considerations here than lesion-specific positioning.
- Coil selection and centring: large flexible or dedicated body-array coils are generally required to achieve symmetric, simultaneous bilateral coverage (e.g., both thighs in a single acquisition) rather than sequential unilateral scans, which improves both efficiency and left-right comparability.
- Symmetric alignment: neutral, symmetric limb rotation and position on both sides is more important in this indication group than in almost any other muscle-imaging context, since asymmetric positioning is a major, avoidable source of spurious left-right signal or size differences that can be misread as pathological asymmetry.
- Immobilisation: padding and support appropriate to reduced muscle bulk/strength, and awareness that a weak patient may be less able to actively hold a position than a healthy comparator, increasing the practical importance of good passive support.
- Comfort strategies: plan for adequate table time and rest breaks in a population that frequently has reduced exercise tolerance and may fatigue during a longer multi-region protocol; consider splitting an extensive survey across two visits when a single session is genuinely not tolerated, documenting this clearly for the interpreting radiologist.
- Common positioning errors: unilateral-only coverage when bilateral comparison was actually required; asymmetric limb rotation between sides, undermining pattern-recognition comparison; insufficient craniocaudal coverage to capture the full muscle group relevant to the suspected disease pattern (e.g., imaging only the mid-thigh when proximal or distal-predominant involvement is diagnostically relevant).
- Practical technologist checks before starting: confirm whether bilateral coverage is required per the clinical question; confirm coil and FOV provide truly symmetric coverage of both sides; confirm craniocaudal extent matches the muscle groups relevant to the clinical question rather than a generic default.
4. Standard Protocol Design
4.1 Mandatory Core Sequences
| # | Sequence | Plane | Status |
|---|---|---|---|
| 1 | T1-weighted, non-fat-suppressed (for fatty replacement grading) | Axial | Mandatory |
| 2 | Fluid-sensitive fat-suppressed T2 or STIR (for oedema-like signal) | Axial | Mandatory |
| 3 | T1-weighted or T2-weighted, non-fat-suppressed | Coronal overview | Conditional / mandatory in modern protocol for craniocaudal extent |
| 4 | Two- or three-point Dixon (fat/water separation, semi-quantitative or quantitative fat fraction) | Axial | Mandatory in modern protocol where available; a strong, increasingly standard alternative/complement to sequences 1 and 2 |
| 5 | Bilateral, symmetric coverage of the clinically indicated region(s) | Axial, matched left-right | Mandatory whenever pattern comparison is the clinical question |
4.2 Conditional Sequences
| Sequence | Indication | Plane |
|---|---|---|
| Whole-body or extended multi-segment fat-referenced MRI (typically Dixon-based) | Widespread, unpredictable-distribution disease; clinical trial or research monitoring; certain early-onset/congenital myopathies | Coronal/axial, whole-body protocol |
| Quantitative T2 mapping | Objective, reproducible assessment of oedema-like signal / inflammatory activity, particularly for monitoring over time | Axial |
| Diffusion-weighted imaging / ADC | Adjunct characterisation, e.g., in some inflammatory myopathy or denervation research protocols | Axial |
| Dedicated MR neurography of the relevant plexus/nerve | Suspected discrete, localisable nerve/plexus lesion causing denervation | As dictated by the nerve’s anatomical course |
| Post-contrast fat-suppressed T1 | Selected inflammatory or atypical presentations where enhancement adds diagnostic value, or to exclude a mass-like process (see Section 6) | Axial, matched to pre-contrast |
| Trunk/paraspinal coverage | Suspected axial muscle involvement (e.g., some inflammatory myopathies, bent-spine syndrome, some myopathies with respiratory muscle involvement) | Axial/sagittal as clinically indicated |
4.3 Rationale Summary Per Sequence
T1-weighted non-fat-suppressed sequences are the standard sequence for grading chronic fatty replacement of muscle, which is the imaging correlate of long-standing damage/atrophy across inherited myopathies, chronic inflammatory myopathy, and chronic denervation alike. Fatty infiltration appears as areas of fat-equivalent T1-hyperintensity replacing normal muscle bulk, and its distribution and severity — commonly graded with the widely used four-point semi-quantitative visual scale — is frequently disease-pattern-specific. The principal limitation is that this grading remains observer-dependent and relatively insensitive to early or mild disease, which is one of the main drivers behind the growing use of quantitative fat-fraction techniques.
Fluid-sensitive fat-suppressed T2/STIR sequences detect oedema-like signal, the imaging correlate of active disease in inflammatory myopathy, of subacute denervation, and of some early or exercise-related myopathic change. As in the trauma protocol, the central interpretive caveat is that oedema-like signal is non-specific in isolation; here, the distribution pattern (diffuse vs. patchy, myotomal vs. peripheral-nerve territory, perifascicular vs. diffuse within the muscle) and its combination with the degree of coexisting fatty replacement (fresh disease activity versus chronic damage with acute-on-chronic change) are what generate diagnostic value the MRI examination of denervated musculature shows edema, an increase in the apparent diffusion coefficient and hyperperfusion, and equally, oedema in inflammatory myopathy and in overuse/DOMS can look similar without context.
Dixon-based fat/water separation sequences are increasingly central to this protocol group specifically because they provide, from a single acquisition, both a qualitative anatomical dataset comparable to T1/T2 and a basis for semi-quantitative or fully quantitative fat-fraction measurement, which is more reproducible than visual grading and is now widely used as an outcome measure in natural-history studies and clinical trials of neuromuscular disease a method for measuring skeletal muscle volume and fat content based on whole-body fat-referenced MRI was developed and validated for use in multisite clinical trials of neuromuscular disorders. Their main limitation at the point of routine clinical adoption is that quantitative post-processing pipelines and normative reference ranges are not yet uniformly available in every department, so many centres currently use Dixon output qualitatively/semi-quantitatively rather than as a fully quantitative biomarker.
4.4 Sequence Matching and Cross-Sequence Consistency
Geometric matching between the T1 and fluid-sensitive (or Dixon-derived fat and water) sequences in each plane, and — critically in this indication group — matching between the left and right sides, is essential for reliable pattern-recognition comparison. Unlike the tumor/infection protocol, pre/post-contrast matching is only occasionally relevant here (Section 6) and subtraction is not a routine requirement. For serial monitoring, matching extends across time: reproducing coil, FOV, slice geometry, and limb position at follow-up is at least as important in this indication group as in the trauma protocol, because longitudinal comparison of fatty-replacement grade or fat-fraction value is frequently the entire clinical purpose of a follow-up study.
4.5 Fat Suppression, Contrast-Specific or Region-Specific Technical Modifiers
Fat suppression plays a distinctive, somewhat inverted role in this protocol compared with the trauma and tumor/infection master pages: here, fat signal on the non-fat-suppressed T1 sequence is itself the primary diagnostic target (chronic fatty replacement), so a fully fat-suppressed T1 acquisition would defeat the purpose of that specific sequence. Fat suppression remains necessary, however, on the sequence used to detect oedema-like signal, for the same reasons described in the companion master pages (conspicuity of fluid/oedema against a fat background).
- Spectral fat saturation is a reasonable default for the fluid-sensitive sequence in a well-centred, symmetric bilateral FOV.
- STIR is preferred whenever homogeneous suppression cannot be guaranteed across a wide, bilateral, or asymmetric-contour FOV (a common scenario in this protocol group, given the frequent need for bilateral thigh/calf coverage), accepting the usual signal-to-noise and time trade-off.
- Dixon-based fat/water separation is, in this specific indication group, arguably the single most valuable fat-handling technique, since it simultaneously provides a robust water-only (oedema-sensitive) image, a fat-only image usable for fat-fraction quantification, and combined in-phase/out-of-phase images, from one well-matched acquisition — directly serving both diagnostic purposes (oedema detection and fatty-replacement grading) that are otherwise addressed by two separate, less well-matched sequences.
Field-strength issues broadly mirror the companion pages: at 3 T, wider chemical-shift separation benefits Dixon-based fat-fraction accuracy, at some SAR cost for longer sequences across a large bilateral FOV; at 1.5 T, fat-fraction quantification is well validated and remains widely used in the neuromuscular MRI literature, so field-strength choice for this indication group is more often dictated by department availability and by the specific quantitative pipeline in use than by a strong universal preference.
4.6 Slice Positioning — Complete Technical Reference
Open complete slice-positioning reference
Why slice positioning matters
In this indication group, slice positioning serves a purpose distinct from both companion pages: rather than centring on a single focal abnormality, the goal is standardised, reproducible, bilateral coverage of specific named muscle groups whose relative involvement constitutes the diagnostic pattern. An axial slice level that is not reproducible between sides, or between baseline and follow-up, directly undermines the comparison that is the entire diagnostic purpose of the study.
Planning sequence
Plan from the three-plane localiser using clear, reproducible bony landmarks (e.g., a defined percentage of femoral length, or a fixed distance from the knee joint line for thigh imaging) rather than a purely visual, non-reproducible estimate of “mid-thigh”; document the landmark and the exact level used so that follow-up studies can reproduce it precisely.
Axial planning
- Axial slices should be planned perpendicular to the long axis of the limb, at a small number of standardised levels appropriate to the muscle groups of interest (for example, a defined proximal, mid, and distal thigh level, each referenced to a reproducible bony landmark), rather than a single arbitrary level, since many disease patterns are level-dependent (proximal-predominant versus distal-predominant involvement is itself diagnostically informative in several muscular dystrophies).
- Both limbs must be included within the same axial slice/FOV, or acquired with strictly matched separate coverage, to support reliable left-right comparison.
- Slice thickness in the region of 5–10 mm is commonly used for a survey-style multi-level bilateral protocol, reflecting the different priority here (broad, reproducible, comparative coverage) compared with the finer in-plane detail prioritised in focal lesion imaging; thinner sections may be used for dedicated quantitative fat-fraction protocols where volumetric segmentation accuracy benefits from higher resolution.
Sagittal / coronal (long-axis) planning
- A coronal overview is valuable for confirming the craniocaudal extent of muscle involvement and for planning the standardised axial levels described above; sagittal long-axis imaging is less central to this protocol than to the trauma or tumor/infection pages, since the diagnostic question here is rarely about a single elongated structure’s length.
Oblique planning
Oblique planning is rarely required in this indication group; when a specific nerve’s course needs to be followed for a suspected denervation aetiology, this is more appropriately addressed by a dedicated MR neurography sequence set (Section 4.2) than by an oblique modification of the muscle-imaging planes described here.
Coverage limits
Coverage should be explicitly matched to the muscle groups relevant to the clinical question and, where a specific dystrophy or myopathy pattern is already suspected, tailored to the muscles known to be most discriminative for that pattern; a request for suspected widespread or unpredictable-distribution disease should prompt explicit consideration of the whole-body/multi-segment child protocol (Section 4.2) rather than an ad hoc extension of the regional protocol.
Phase-encoding considerations
Phase-encoding direction is generally set along the shorter FOV dimension, as in the companion pages; for a wide bilateral FOV, anticipate and mitigate vascular pulsation artefact from the femoral or popliteal vessels, and be aware that a wide FOV increases the practical importance of no-phase-wrap/oversampling options to avoid aliasing across the midline between the two limbs.
How to verify symmetry
Confirm that corresponding bony landmarks (e.g., the same percentage of femoral length, or the same distance from a joint line) appear at matched slice positions on both sides; document any known pre-existing asymmetry (prior injury, prior surgery, known unilateral disease) so that true disease-related asymmetry is not confounded with an unrelated baseline difference.
Common errors
Unilateral-only imaging when bilateral comparison was clinically required; non-reproducible, purely visual level selection that cannot be matched at follow-up; inconsistent limb rotation between sides; insufficient craniocaudal coverage to capture a proximal-versus-distal gradient that is itself diagnostically relevant.
Serial follow-up reproducibility
This is arguably the single most important technical theme in this entire protocol group: document the exact bony landmark, distance, coil, and FOV used, and reproduce them precisely at every follow-up study, since longitudinal comparison of fatty-replacement grade or quantitative fat fraction is frequently the specific reason the follow-up study was requested.
Automated planning tools
Automated, landmark-based slice-planning tools are more actively used and validated in this indication group than in the trauma or tumor/infection protocols, particularly within structured multicentre natural-history studies and clinical trials that require rigorously standardised, reproducible muscle-level selection across sites and over time; nonetheless, manual verification against the stated bony landmark remains standard practice outside dedicated trial workflows.
Bibliography for this section
5. Optimisation Strategy
5.1 Artifact Reduction by Source
| Artefact | Cause | Where it appears | What it can mimic | Reduction strategy | When it invalidates the exam |
|---|---|---|---|---|---|
| Motion | Weakness, fatigue, reduced positioning tolerance | Blurring/ghosting across the protocol | Pseudo-oedema or blurred fat/muscle boundaries affecting grading | Adequate support, rest breaks, prioritised sequence order, shorter individual sequences | Motion precluding reliable left-right or level-matched comparison |
| Incomplete/inhomogeneous fat suppression | Wide bilateral FOV, field inhomogeneity | FOV periphery, between the two limbs | False oedema-like signal, confounding activity assessment | Centre carefully, use STIR or Dixon rather than spectral technique across a very wide FOV | Extensive inhomogeneity across the muscle groups being graded |
| Chemical shift | Fat–water interface | Fat–muscle boundaries | Altered apparent muscle margin, affecting volumetric/fat-fraction accuracy | Adequate bandwidth, awareness at post-processing and interpretation | Rarely invalidates; a recognised pitfall for quantitative pipelines |
| Aliasing/wrap-around | FOV smaller than the combined bilateral anatomy | Midline between limbs or opposite FOV edge | Superimposed anatomy misread as pathology | Adequate FOV, no-phase-wrap/oversampling | Wrap-around directly over a muscle group being graded |
| Vascular pulsation | Femoral/popliteal vessels | Along phase-encoding direction from the vessel | Linear signal abnormality within muscle | Saturation bands, phase-encoding direction selection | Pulsation directly overlying a muscle group of clinical interest |
| Susceptibility | Rarely relevant unless metal/haemorrhage present | Local distortion | Artefactual signal loss mimicking severe atrophy | Standard susceptibility-aware sequence parameters | Uncommon in this indication group unless hardware is present |
| Respiratory motion | Trunk/paraspinal imaging | Blurring, ghosting craniocaudally | Diffuse signal change in axial musculature | Breath-hold or respiratory-triggered options where trunk coverage is added | Uncontrolled respiratory motion over the axial muscles of interest |
5.2 Protocol Efficiency and Throughput
A “premium” protocol in this indication group typically means extended coverage (additional levels, bilateral calves in addition to thighs, or a move to whole-body imaging) and the addition of quantitative fat-fraction or T2-mapping sequences, rather than higher in-plane resolution as such; this is justified in diagnostic uncertainty, in research/trial contexts, and in serial monitoring where a quantitative outcome measure is specifically required. A shortened protocol — bilateral T1 and fluid-sensitive (or a single Dixon acquisition serving both purposes) at a small number of standardised levels — is appropriate for the more routine referral where the question is pattern recognition to support a working diagnosis. Two-dimensional multi-slice, multi-level acquisition remains the practical backbone of this protocol; 3D isotropic acquisition has a more specific role here than in trauma imaging when volumetric segmentation for quantitative fat-fraction or muscle-volume measurement is the goal, since isotropic data materially improves segmentation accuracy, but 2D remains entirely adequate, faster, and more robust for routine qualitative/semi-quantitative clinical assessment.
5.3 Field Strength Considerations
At 3 T, improved signal-to-noise supports either finer resolution or shorter acquisition across the wide bilateral FOV typically required in this protocol, and Dixon-based fat-fraction accuracy benefits from wider chemical-shift separation; SAR becomes a more relevant constraint for longer fat-saturated sequences across a large combined bilateral FOV. At 1.5 T, quantitative fat-fraction methodology is well validated in the published neuromuscular MRI literature and remains a robust, widely used field strength for this indication group, so the departmental choice is again generally guided by scanner/coil availability and by which specific quantitative pipeline (validated at a particular field strength) the department intends to use, rather than by a strong universal preference for one field strength over the other.
6. Contrast Use Principles Specific to Muscle Neuromuscular Disorders
Universal GBCA safety screening belongs to the general MRI preparation page and is not repeated here; the project standard of macrocyclic agents applies whenever contrast is used. Contrast administration is, in contrast to the tumor/infection master page, not a routine or default component of the generic neuromuscular protocol.
6.1 Non-Contrast Standard Protocol — Sufficient For
The large majority of referrals in this indication group — pattern-recognition work-up of suspected inherited myopathy or muscular dystrophy, activity/damage assessment in known or suspected inflammatory myopathy, and denervation-pattern assessment for a suspected neuropathy, plexopathy, or radiculopathy — are adequately and completely assessed with the non-contrast T1/fluid-sensitive/Dixon protocol described in Section 4. Longitudinal monitoring of fatty replacement or fat fraction likewise does not require contrast.
6.2 Gadolinium Indicated — Region-Specific Contexts
Contrast should be considered, rather than used routinely, in a small number of specific circumstances: when a mass-like or unusually focal area of muscle abnormality is identified during a neuromuscular work-up and a coexisting tumor, abscess, or focal pseudotumor-like inflammatory lesion needs to be excluded — in which case the study should, in practice, be redirected toward the dedicated tumor/infection pathway; in selected inflammatory myopathy presentations where the referring clinician specifically requests enhancement characteristics to help characterise an atypical or focal pattern of muscle involvement; and in research or selected complex diagnostic contexts where perilesional or perifascial enhancement is being specifically assessed as an experimental activity marker. As with the companion master pages, STIR should not be used on any post-contrast sequence, and spectral fat saturation or Dixon-based fat suppression should be used instead whenever post-contrast fat-suppressed imaging is required.
6.3 Post-Contrast Acquisition Timing
Where contrast is used in this indication group, standard early post-contrast imaging is generally sufficient; dedicated dynamic or delayed protocols are not part of the generic mandatory approach here and would only be considered within a specific research or highly atypical diagnostic context. Injection time and sequence timing relative to injection should be documented whenever contrast is given, exactly as in the companion master pages.
7. Reporting Essentials
7.1 Interpretation Framework
The report should reason through the examination along axes that are somewhat distinct from the companion master pages: acute/active (oedema-like signal without significant fatty replacement) versus chronic/damaged (fatty replacement, atrophy, with or without superimposed acute change); diffuse versus patterned/selective involvement, with explicit description of which named muscles are relatively spared versus selectively involved, since this specific pattern is frequently the most diagnostically valuable single piece of information in the report; symmetric versus asymmetric involvement, which helps distinguish a systemic myopathic process (typically more symmetric) from a focal neuropathic, plexopathic, or radiculopathic process (typically following a nerve or myotomal distribution); and, where relevant, myotomal/peripheral-nerve-territory distribution versus a distribution that does not fit a recognisable neurogenic pattern, which supports or argues against a denervation aetiology.
7.2 Mandatory Reporting Checklist
The report should not omit: an explicit, named list of which muscles were assessed and which specific muscles show oedema-like signal and/or fatty replacement, with a severity grade for the latter using a stated, consistent scale; an explicit statement of distribution pattern (symmetric/diffuse, patterned/selective, or myotomal/nerve-territory) rather than only a muscle-by-muscle description; comparison with any prior imaging, with explicit comment on interval change in both oedema-like signal and fatty-replacement grade; technical limitations (motion, incomplete coverage, asymmetric positioning) that could affect pattern interpretation or serial comparison; whether contrast was used and why, if applicable; and, where the pattern is suggestive of a specific diagnostic category, a statement to that effect phrased appropriately as imaging-supported differential diagnosis rather than a definitive diagnosis, given that genetic/histological confirmation remains the reference standard for most entities in this group.
7.3 Structured Reporting
Reports should follow the standard structure of indication, technique (explicitly stating which muscles/regions were covered, bilaterally or unilaterally, and which sequences including whether Dixon/quantitative fat fraction was obtained), comparison, findings, impression, and limitations, with critical-result communication reserved for the uncommon scenario where an unexpected mass, infective collection, or acute red-flag finding (Section 2.2) is identified during what was intended as a routine neuromuscular work-up.
7.4 Incidental Findings — Clinical Decision Framework
- Usually benign: minor, age-appropriate degrees of fatty replacement in specific muscles that are a recognised, non-pathological finding in older patients; small, well-characterised post-biopsy change at a known, documented biopsy site.
- Follow-up may be needed: an asymmetric pattern of muscle involvement that does not fit a recognisable myopathic, inflammatory, or neurogenic pattern and cannot be confidently explained by the available clinical history.
- Urgent or clinically important: any focal, mass-like lesion identified during a neuromuscular work-up that raises concern for a tumor or infective collection rather than the expected diffuse/patterned myopathic or neurogenic change, which should be redirected to the dedicated tumor/infection pathway with direct communication to the referring clinician rather than folded into the neuromuscular report as an incidental finding.
8. MRI Technologist Pearls
8.1 Sequence Order Logic
Acquire the bilateral fluid-sensitive or Dixon sequence early, since it provides both oedema-like signal information and, via the fat-only channel, a first-pass impression of fatty-replacement distribution, giving the most complete single-sequence answer if the patient cannot tolerate the full protocol; a non-fat-suppressed T1 sequence for detailed fatty-replacement grading can follow.
8.2 Positioning Tricks
Use reproducible bony landmarks, not visual estimation, for level selection; confirm bilateral symmetry of positioning before acquiring the core sequences, since asymmetric positioning is one of the most consequential and avoidable sources of error in this specific protocol group; for patients with reduced tolerance, plan the most diagnostically critical bilateral levels first and add secondary levels only if time and tolerance allow.
8.3 Fast Salvage Protocol
| Priority | Sequence | Approximate time | What it covers |
|---|---|---|---|
| 1 | Bilateral axial Dixon or fluid-sensitive fat-suppressed sequence at the primary standardised level | 4–6 min | Oedema-like signal and a first impression of fatty-replacement distribution, bilaterally |
| 2 | Bilateral axial T1-weighted at the same level(s) | 3–4 min | Detailed fatty-replacement grading |
| 3 | Additional standardised levels (proximal/distal) if tolerated | Variable | Extends the pattern assessment beyond a single level |
If the patient cannot tolerate further imaging, sequence 1 alone at a well-chosen, reproducible level provides a clinically useful, if incomplete, first impression of both disease activity and chronic change; sequences 1 and 2 together at a single well-chosen level represent a reasonable practical minimum for a reportable pattern assessment.
8.4 Common Avoidable Errors
| Error | Consequence | Prevention |
|---|---|---|
| Unilateral-only imaging | Cannot assess symmetry, the central diagnostic axis in this indication group | Confirm bilateral coverage requirement before starting |
| Non-reproducible, visually estimated slice level | Follow-up study cannot be reliably compared to baseline | Use and document a specific bony-landmark-referenced level |
| Asymmetric limb positioning between sides | Spurious apparent asymmetry misread as pathology | Verify symmetric positioning before acquiring core sequences |
| Insufficient craniocaudal coverage | Missed proximal-versus-distal gradient that is itself diagnostic | Cover the full muscle group(s) relevant to the suspected pattern, not a single arbitrary level |
| Contrast given routinely without a specific indication | Unnecessary GBCA exposure and cost without added diagnostic value for the standard indication | Reserve contrast for the specific scenarios in Section 6.2 |
9. Quality Control Checklist
- Bilateral, symmetric coverage confirmed for the clinically relevant muscle groups, at reproducible, landmark-referenced levels.
- No significant motion degradation affecting left-right or level-to-level comparison.
- Both T1 (fatty replacement) and fluid-sensitive/Dixon (oedema-like signal) information available for every muscle group assessed.
- Fat suppression homogeneous across the full bilateral FOV on the fluid-sensitive sequence; STIR or Dixon substituted where spectral technique is inadequate across the wide FOV.
- Correct laterality and orientation labelling, verified against the request.
- Documentation of the exact bony landmarks and levels used, to support future serial comparison.
- Contrast administration and injection timing documented if used, with a stated indication.
- Comparison with prior studies performed, and any positioning differences between studies explicitly noted.
- Quantitative fat-fraction or T2-mapping post-processing (if performed) reviewed for quality before the study is finalised.
10. Advanced Technical Parameters
Open advanced technical reference
T1-weighted spin-echo (non-fat-suppressed) — chronic fatty replacement grading - Tissue contrast logic: fat-equivalent T1-hyperintensity within muscle bulk represents chronic fatty replacement, the imaging correlate of long-standing myopathic or neurogenic damage. - Acquisition design: representative parameters TR ≈ 500–900 ms, TE ≈ 10–15 ms, slice thickness ≈ 5–10 mm for a standard multi-level bilateral survey, thinner where volumetric quantification is the goal. - Diagnostic advantages: widely available, well-validated basis for semi-quantitative visual grading (e.g., the commonly used four-point scale). - Limitations: observer-dependent; relatively insensitive to mild/early fatty change compared with quantitative fat-fraction techniques. - Fat suppression role: deliberately not fat-suppressed, since fat signal is the diagnostic target of this sequence.
Fluid-sensitive fat-suppressed T2/STIR — oedema-like signal / disease activity - Tissue contrast logic: increased extracellular water in inflamed, denervated, or otherwise actively diseased muscle produces T2 prolongation and conspicuous hyperintensity against a suppressed-fat background. - Acquisition design: representative parameters TR ≈ 3,500–6,000 ms, TE ≈ 40–80 ms, or STIR with an inversion time appropriate to field strength, slice thickness matched to the T1 sequence at the same level. - Diagnostic advantages: sensitive marker of active disease in inflammatory myopathy and of subacute denervation; a key input to distinguishing “active” from “burnt-out/chronic-only” disease. - Limitations: non-specific in isolation, as discussed in Section 4.3; distribution pattern and correlation with the T1/fat-fraction findings are required for diagnostic value. - Fat suppression role: mandatory; spectral technique a reasonable default for a moderate bilateral FOV, STIR preferred for a wider or less homogeneous FOV.
Dixon-based fat/water separation (two- or three-point) — combined qualitative and quantitative assessment - Tissue contrast logic: chemical-shift-based separation of fat and water signal from a single acquisition, generating water-only (oedema-sensitive), fat-only (fatty-replacement-sensitive), and combined in-phase/out-of-phase images. - Acquisition design: representative parameters vary by vendor implementation; multi-echo gradient-echo acquisitions with echo spacing chosen to sample the fat–water chemical-shift cycle are typical, with slice thickness selected according to whether the goal is routine qualitative assessment (thicker, faster) or volumetric quantitative fat-fraction/segmentation work (thinner, near-isotropic where feasible) a whole-body fat-referenced MRI protocol using T1-weighted two-point Dixon imaging covering the torso and upper and lower extremities has been developed and validated for multisite quantitative use. - Diagnostic advantages: efficient, well-matched combined dataset serving both diagnostic purposes of this protocol; basis for increasingly validated quantitative fat-fraction biomarkers used in natural-history studies and clinical trials. - Limitations: quantitative post-processing pipelines and normative reference data are not yet uniformly standardised or available in every department; qualitative/semi-quantitative use is more widely accessible at present than fully quantitative use. - 2D vs 3D: 3D acquisition offers a genuine advantage here for volumetric muscle segmentation and fat-fraction quantification, more so than in the companion master pages, though 2D multi-slice remains adequate for routine qualitative clinical assessment.
Bibliography for this section
11. Evidence Gaps & Ongoing Debate
- Quantitative versus semi-quantitative fat assessment: quantitative fat-fraction mapping is increasingly validated as a reproducible outcome measure, but standardisation of acquisition, post-processing, and normative reference ranges across departments and vendors is incomplete, and semi-quantitative visual grading remains the more universally accessible clinical default at this stage.
- Optimal abbreviated protocol for routine diagnostic (as opposed to research) use is not yet firmly established; departments vary in how many levels and which muscle groups are considered a sufficient generic survey before escalating to whole-body imaging.
- Role of quantitative T2 mapping as a routine disease-activity biomarker in inflammatory myopathy and denervation is an active research area, with growing but not yet universally adopted clinical evidence.
- Contrast necessity in borderline inflammatory presentations: whether post-contrast imaging adds enough incremental value over fluid-sensitive sequences to justify routine use in atypical inflammatory myopathy presentations remains debated and is not settled by high-level comparative evidence.
- 2D versus 3D acquisition for volumetric/quantitative muscle assessment: 3D offers clear segmentation advantages but comparative outcome evidence for routine (non-trial) clinical practice is still developing.
- AI-assisted muscle segmentation and pattern classification is a rapidly growing area, with open, community-supported efforts toward normative reference datasets, but this is not yet a standard, validated component of routine clinical reporting.
12. Evidence-Based References
A. Guidelines / Consensus / Society Recommendations
B. Systematic Reviews / Meta-analyses
C. Important Prospective / Original Studies
D. Technical MRI Papers
E. Landmark Historical References
End of document — MRI Muscle in Neuromuscular Disorders — Generic Standard Protocol — MRIninja Master Page v1.0 — July 2026
Child Protocols
Clinical pages derived from this master protocol. These pages document what changes for specific indications.
No child protocols have been published yet.
Related Protocols
Recent PubMed search for this protocol